|
시장보고서
상품코드
2083401
생물학적 종자 처리 시장 : 처리 방법별, 종자 유형별, 생물제별, 제제 형태별, 작물 유형별, 판매 채널별 - 세계 시장 예측(2026-2032년)Biological Seed Treatment Market by Treatment Type, Seed Type, Biological Agent, Formulation, Crop Type, Sales Channel - Global Forecast 2026-2032 |
||||||
360iResearch
생물학적 종자 처리 시장은 2032년까지 연평균 복합 성장률(CAGR) 9.29%로 성장해 31억 8,000만 달러 규모로 확대될 것으로 예측됩니다.
| 주요 시장 통계 | |
|---|---|
| 기준 연도(2025년) | 17억 1,000만 달러 |
| 추정 연도(2026년) | 18억 6,000만 달러 |
| 예측 연도(2032년) | 31억 8,000만 달러 |
| CAGR(%) | 9.29% |
생물학적 종자 처리는 틈새 시장용 자재 범주에서 벗어나, 지속 가능한 작물 보호, 종자 기능 향상, 그리고 재생 농업의 핵심 요소로 자리매김하고 있습니다. 이 시장은 잔류물을 중시하는 식품 생산에 대한 수요 증가, 일부 합성 작물 보호 화학 물질에 대한 규제, 그리고 가뭄, 염해, 병해의 압박 속에서 작물의 생육을 개선해야 할 필요성에 의해 형성되었습니다. 종자 처리용 미생물 제제, 식물 유래 제제, 생리활성제 및 바이오 살균제는 고부가가치 종자를 보호하는 동시에 발아 초기 뿌리의 활력과 양분 이용 효율을 향상시키기 위해 점점 더 널리 사용되고 있습니다.
검증된 농업 지표 역시 이 시장의 기회를 뒷받침하고 있습니다. 유엔 식량농업기구(FAO)는 농업이 전 세계 담수 취수의 주요 이용자라고 지적하고 있으며, 세계은행과 OECD·FAO의 전망 역시 경작지의 생산성, 식량 안보, 기후 변화에 대한 회복력에 대한 압박이 계속해서 커지고 있음을 강조하고 있습니다. 이러한 배경 하에, 생물학적 종자 처리는 종자에 직접 소량을 처리함으로써 광범위한 살포에 비해 밭에 노출되는 양이 적고, 정밀 파종 시스템과의 호환성도 갖춘, 표적을 좁혀 적용하는 모델을 제공합니다.
수요가 가장 높은 분야로는 생물학적 종자 처리, 미생물을 이용한 종자 코팅, 생물 유래 살균제를 이용한 종자 처리, 종자에 대한 생리활성제 처리, 지속 가능한 작물 보호, 토양 건강, 그리고 통합 해충 관리가 있습니다. 생산자, 종자 회사, 규제 당국이 수확량 확보, 환경 부담 저감, 그리고 탄력적인 농업 생산이라는 목표를 향해 뜻을 모으고 있는 지역에서 그 도입이 가장 활발히 이루어지고 있습니다.
생물학적 종자 처리 분야의 획기적인 변화
생물학적 종자 처리 분야는 농학, 규제, 기술의 융합을 통해 재편되고 있습니다. 농가에서는 통합 해충 관리 프로그램에 포함시키면서도 발아와 작물의 정착을 보호해 주는 제품을 요구하고 있습니다. 종자 회사는 이에 부응하여, 특히 옥수수, 대두, 곡물, 면화, 채소, 콩류용 프리미엄 종자 패키지에 생리활성 물질을 포함시키고 있습니다.
인공지능(AI)의 누적 영향
인공지능(AI)은 생물학적 종자 처리 분야의 혁신을 촉진하는 실질적인 원동력이 되어가고 있습니다. AI를 활용한 선별을 통해 질소 고정, 인의 용해, 식물 호르몬 생성, 항진균 활성, 스트레스 내성 등의 특성을 지닌 미생물 균주를 특정할 수 있습니다. 유전체학, 대사체학, 토양 데이터 세트 및 포장 시험 결과를 결합함으로써, 개발자는 생물학적 발견 과정에서 시행착오를 줄이고, 포장 시험에서 성공할 확률이 높은 후보를 우선적으로 선정할 수 있습니다.
생물학적 종자 처리에 관한 주요 지역별 인사이트
아시아태평양은 광대한 경작 면적, 집약적인 소규모 농가 시스템, 그리고 토양 건강과 식량 안보에 대한 정책적 관심이 높아지고 있는 점이 맞물려, 생물학적 종자 처리 분야에서 큰 잠재력을 지닌 지역입니다. 중국과 인도는 쌀, 밀, 옥수수, 면화, 콩류, 유지종자를 통해 수요의 중심을 차지하고 있는 반면, 일본, 한국, 호주는 선진적인 종자 시스템과 엄격한 품질 기준을 통해 고품질 제품의 채택을 뒷받침하고 있습니다. FAO 및 OECD-FAO의 농업 전망 보고서에 따르면, 아시아가 전 세계 식량 수요와 작물 생산의 회복력 측면에서 중심적인 역할을 하고 있다고 일관되게 지적되고 있으며, 이에 따라 종자 처리용 생물제제는 생산성, 영양 효율, 기후 변화 적응 측면에서 중요한 역할을 수행하고 있습니다.
아세안(ASEAN), GCC, EU, 브릭스(BRICS), G7, 나토(NATO)의 주요 그룹 분석
아세안 국가들에서는 쌀, 옥수수, 채소, 농장 작물 등이 습한 환경으로 인한 병해의 위협과 변동이 심한 토양 조건에 노출되어 있기 때문에 생물학적 종자 처리의 중요성이 점점 더 커지고 있습니다. 인도네시아, 베트남, 태국, 필리핀에서는 종자 시스템의 전문화가 진행되고 있는 점이 도입을 뒷받침하고 있지만, 제품에 대한 교육, 현지 시험 데이터, 그리고 적정한 가격이 여전히 결정적인 요인으로 작용하고 있습니다. GCC 지역에서는 경작 가능한 토지가 제한적이고 수자원도 부족하기 때문에 특히 보호 재배, 사료 작물 및 식량 안보 분야에서 고효율 농업 자재의 도입이 절실히 요구되고 있습니다.
생물학적 종자 처리 도입과 관련된 주요 국가의 동향
미국은 옥수수, 대두, 면화, 곡물 분야에서 처리 종자의 사용량이 많으며, 미국 농무부(USDA)의 연구 네트워크, 대학의 보급 프로그램, 민간 생물학적 플랫폼, 그리고 정밀 농업의 도입에 힘입어 상업적 규모에서 선도적인 위치를 차지하고 있습니다. 캐나다에서는 카놀라, 곡물, 콩류 및 접종제에 대한 수요가 높은 반면, 멕시코에서는 수출용 원예작물, 옥수수 및 보호재배에 대한 수요가 복합적으로 나타나고 있습니다. 브라질은 대두에 대한 접종이 정착되어 있으며, 열대 생산 시스템이 생물학적 질소 고정, 병해 억제 및 스트레스 경감에 대한 수요를 창출하고 있기 때문에 가장 중요한 도입 시장 중 하나가 되었습니다.
업계 리더를 위한 실천적인 제안
업계의 선도 기업은 광범위한 생물학적 효능에 대한 주장보다는 밭에서 입증된 성능을 우선시해야 합니다. 토양의 유형, 파종 시기, 종자의 유전적 특성, 화학 약품과의 병용 조합을 종합적으로 다루는 다지역 시험은 성능의 일관성을 입증하고 생산자의 신뢰를 뒷받침하기 위해 필수적입니다. 제품 포트폴리오는 작물, 지역, 그리고 ‘뿌리 활력’, ‘병해 억제’, ‘영양분 이용 효율’, ‘비생물적 스트레스 내성’ 등의 이용 사례별로 분류해야 합니다.
조사 방법
본 요약본은 시장 정보의 모범 사례에 따라 2차 조사를 중심으로 한 방법을 사용하여 작성되었습니다. 정보 출처에는 FAO, OECD-FAO, 세계은행, USDA, EPA, 유로스타트, 각국 농업부, 대학의 보급 간행물, 규제 당국 등에서 제공하는 공개 데이터 및 정책 자료가 포함됩니다. 이러한 정보원을 활용하여 경작 면적, 투입 자재의 지속가능성 동향, 물 스트레스, 농약 정책, 생물 유래 자재에 대한 규제, 종자 부문의 발전과 같은 거시적인 촉진요인을 검증하고 있습니다.
결론
생물학적 종자 처리는 지속 가능한 집약화를 위한 필수적인 수단으로 자리 잡고 있으며, 생산자가 종자에 대한 투자를 보호하고 작물의 초기 생육을 촉진하며, 기존의 화학 물질에만 의존하는 프로그램에 대한 의존도를 낮추는 데 기여하고 있습니다. 그 가치는 현지 포장 데이터를 통해 생물학적 유효성이 입증되고, 전문적인 종자 처리 시스템에 통합되었을 때 가장 높아집니다.
자주 묻는 질문
목차
제1장 서문
제2장 조사 방법
제3장 주요 요약
제4장 시장 개요
제5장 시장 인사이트
제6장 AI의 누적 영향(2026년)
제7장 생물학적 종자 처리 시장 : 처리 방법별
제8장 생물학적 종자 처리 시장 : 종자 유형별
제9장 생물학적 종자 처리 시장 : 생물제별
제10장 생물학적 종자 처리 시장 : 제제 형태별
제11장 생물학적 종자 처리 시장 : 작물 유형별
제12장 생물학적 종자 처리 시장 : 판매 채널별
제13장 생물학적 종자 처리 시장 : 지역별
제14장 생물학적 종자 처리 시장 : 그룹별
제15장 생물학적 종자 처리 시장 : 국가별
제16장 경쟁 구도
제17장 기업 개요
KTH 26.07.15The Biological Seed Treatment Market is projected to grow by USD 3.18 billion at a CAGR of 9.29% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.71 billion |
| Estimated Year [2026] | USD 1.86 billion |
| Forecast Year [2032] | USD 3.18 billion |
| CAGR (%) | 9.29% |
Biological seed treatment is moving from a niche input category to a core component of sustainable crop protection, seed enhancement, and regenerative agriculture. The market is shaped by rising demand for residue-conscious food production, restrictions on several synthetic crop protection chemistries, and the need to improve crop establishment under drought, salinity, and disease pressure. Seed-applied microbials, botanicals, biostimulants, and biofungicides are increasingly used to protect high-value seed while improving early root vigor and nutrient use efficiency.
Verified agricultural indicators reinforce the opportunity. The FAO identifies agriculture as the dominant global user of freshwater withdrawals, while the World Bank and OECD-FAO outlooks continue to highlight pressure on arable land productivity, food security, and climate resilience. Against this backdrop, biological seed treatment offers a targeted delivery model: small application volumes placed directly on the seed, lower field exposure than broad-acre sprays, and compatibility with precision planting systems.
The strongest demand themes include biological seed treatment, microbial seed coating, biofungicide seed treatment, seed-applied biostimulants, sustainable crop protection, soil health, and integrated pest management. Adoption is strongest where growers, seed companies, and regulators align around yield protection, reduced environmental load, and resilient agricultural production.
Transformative Shifts in Biological Seed Treatment
The biological seed treatment landscape is being reshaped by a convergence of agronomy, regulation, and technology. Farmers are demanding products that protect germination and stand establishment while fitting into integrated pest management programs. Seed companies are responding by embedding biological actives into premium seed packages, especially for corn, soybean, cereals, cotton, vegetables, and pulses.
A major shift is the move from single-strain microbial products toward multi-mode formulations that combine beneficial bacteria, fungi, enzymes, humic substances, seaweed extracts, and targeted nutrients. This reflects field-level evidence that biological performance depends on compatibility with seed genetics, soil microbiome, climate, seed treatment polymers, and chemical co-treatments.
Regulatory and retailer expectations are also changing. The European Green Deal and Farm to Fork strategy, national pesticide reduction plans, and residue management programs across food supply chains are encouraging alternatives that support sustainable crop protection. At the same time, large-scale row crop adoption depends on proof of shelf stability, predictable field performance, and seamless integration with commercial seed treatment equipment.
Cumulative Impact of Artificial Intelligence
Artificial intelligence is becoming a practical accelerator for biological seed treatment innovation. AI-enabled screening helps identify microbial strains with traits linked to nitrogen fixation, phosphorus solubilization, phytohormone production, antifungal activity, and stress tolerance. By combining genomics, metabolomics, soil datasets, and field trial results, developers can reduce trial-and-error in biological discovery and prioritize candidates with higher probability of field success.
AI is also improving formulation and seed coating performance. Predictive models can evaluate microbial compatibility with polymers, drying conditions, storage temperature, and chemical seed treatment partners. This is critical because biological seed treatments must remain viable from production through planting while performing under variable soil moisture and temperature conditions.
On the farm, AI-supported decision platforms can match biological seed treatment recommendations with soil health indicators, disease forecasts, planting date, hybrid selection, and regional weather risk. The cumulative impact is a more evidence-based market in which efficacy claims, product positioning, and return-on-investment analysis become more transparent for growers and channel partners.
Key Regional Insights for Biological Seed Treatment
Asia-Pacific is a high-potential region for biological seed treatment because it combines large crop acreage, intensive smallholder systems, and increasing policy attention to soil health and food security. China and India anchor demand through rice, wheat, corn, cotton, pulses, and oilseeds, while Japan, South Korea, and Australia support premium adoption through advanced seed systems and strong quality standards. FAO and OECD-FAO agricultural outlooks consistently identify Asia as central to global food demand and crop production resilience, making seed-applied biologicals relevant for productivity, nutrient efficiency, and climate adaptation.
North America remains one of the most commercially mature regions due to advanced seed treatment infrastructure, broad adoption of treated seed in corn and soybean, and strong public and private biological research activity. The United States and Canada benefit from well-developed distribution, university extension research, and grower familiarity with inoculants and biofungicides. Latin America is expanding rapidly, led by Brazil and Mexico, where soybean inoculation, tropical disease pressure, and large-scale row crop production support microbial and biostimulant seed treatment adoption.
Europe is shaped by regulatory scrutiny, pesticide reduction goals, and demand for low-residue crop production. The European Union's sustainability agenda supports interest in biological alternatives, although product approval timelines and evidence requirements remain important barriers. The Middle East and Africa represent emerging opportunities where seed treatment can help improve establishment under heat, drought, and soil fertility constraints; however, adoption depends on seed sector modernization, farmer training, registration pathways, and reliable distribution.
Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO
ASEAN countries are increasingly relevant for biological seed treatment because rice, corn, vegetables, and plantation crops are exposed to humid disease pressure and variable soil conditions. Adoption is supported by rising professionalization of seed systems in Indonesia, Vietnam, Thailand, and the Philippines, although product education, local trial data, and affordability remain decisive factors. In the GCC, limited arable land and water scarcity create a strong rationale for high-efficiency agricultural inputs, especially in protected cultivation, forage, and food security initiatives.
The European Union is a policy-led demand center where biological seed treatment aligns with integrated pest management, pesticide risk reduction, and soil biodiversity objectives. EU buyers often require robust data on efficacy, environmental safety, and traceability, making the region attractive for science-backed suppliers. BRICS economies are strategically important because Brazil, Russia, India, China, and South Africa collectively represent major grain, oilseed, pulse, and horticultural production systems, creating diverse use cases for microbial inoculants, biofungicides, and seed-applied biostimulants.
G7 markets provide commercial maturity, regulatory structure, and advanced seed technology platforms, particularly in the United States, Canada, Japan, Germany, France, Italy, and the United Kingdom. NATO countries overlap with several advanced agricultural markets where resilience, domestic food security, and sustainable intensification are policy priorities. Across these groups, market leadership depends on localized trial data, regulatory compliance, quality assurance, and integration with seed company treatment protocols.
Key Country Insights for Biological Seed Treatment Adoption
The United States leads in commercial scale due to high treated-seed use in corn, soybean, cotton, and cereals, supported by USDA research networks, university extension programs, private biological platforms, and precision agriculture adoption. Canada shows strong fit in canola, cereals, pulses, and inoculants, while Mexico combines export horticulture, corn, and protected agriculture demand. Brazil is one of the most important adoption markets because soybean inoculation is well established and tropical production systems create demand for biological nitrogen fixation, disease suppression, and stress mitigation.
In Europe, the United Kingdom, Germany, France, Italy, and Spain are shaped by sustainability requirements, residue management, and strong seed quality standards. Germany and France are especially important for cereals and oilseeds, while Spain and Italy offer opportunities in vegetables, horticulture, and Mediterranean stress conditions. Russia remains significant because of its large wheat, barley, sunflower, and oilseed area, although market access, registration, and supply chain considerations influence adoption.
China and India are central to long-term adoption because of their scale in rice, wheat, corn, cotton, pulses, and oilseeds, and because both countries have policy interest in reducing excessive chemical input use and improving soil health. Japan and South Korea represent high-value, quality-driven markets where efficacy, safety, and formulation consistency are essential. Australia offers strong opportunities in cereals, pulses, and broad-acre systems exposed to drought and variable soils, making seed-applied biologicals relevant for early vigor, nutrient efficiency, and resilience.
Actionable Recommendations for Industry Leaders
Industry leaders should prioritize field-validated performance over broad biological claims. Multi-location trials across soil types, planting windows, seed genetics, and chemical co-treatment combinations are essential for proving consistency and supporting grower confidence. Product portfolios should be segmented by crop, geography, and use case, such as root vigor, disease suppression, nutrient efficiency, or abiotic stress tolerance.
Organizations should strengthen partnerships with seed producers, retailers, universities, and digital agronomy platforms. Biological seed treatment success depends on formulation stability, applicator compatibility, accurate stewardship, and clear return-on-investment communication. Leaders should also invest in regulatory-ready dossiers, transparent strain identification, quality control testing, and supply chain resilience for live microbial products.
A winning strategy combines science-backed innovation with practical deployment. Firms that integrate AI-enabled discovery, localized agronomic data, farmer education, and sustainable crop protection positioning will be better placed to capture premium seed treatment demand while meeting tightening environmental and food safety expectations.
Research Methodology
This executive summary is developed using a secondary-research-led methodology aligned with market intelligence best practices. Inputs include publicly available data and policy references from organizations such as the FAO, OECD-FAO, World Bank, USDA, EPA, Eurostat, national agriculture ministries, university extension publications, and regulatory authorities. These sources are used to validate macro drivers including crop acreage, input sustainability trends, water stress, pesticide policy, biological input regulation, and seed sector development.
Market interpretation is based on triangulation across agronomic evidence, regulatory context, crop production patterns, technology adoption, and commercial seed treatment practices. Biological seed treatment categories considered include microbial inoculants, biofungicides, biostimulants, botanical actives, nutrient-enhancing treatments, and compatible seed coating systems.
The analysis avoids unsupported market sizing, share, and forecasting claims and emphasizes verified, data-backed indicators. Insights are structured for executive decision-making, and web readability while maintaining industry-specific authority.
Conclusion
Biological seed treatment is becoming an essential tool for sustainable intensification, helping growers protect seed investment, improve early crop establishment, and reduce reliance on conventional chemical-only programs. Its value is strongest where biological efficacy is validated through local field data and integrated into professional seed treatment systems.
Regional momentum differs, but the direction is clear: North America and Europe provide mature regulatory and commercial frameworks, Latin America and Asia-Pacific offer large-scale adoption opportunities, and the Middle East and Africa present resilience-driven use cases. The next phase of leadership will be defined by formulation quality, AI-enabled discovery, regulatory credibility, and measurable agronomic outcomes.
For industry participants, the opportunity lies not only in selling biological products but in delivering trusted seed-applied solutions that improve productivity, sustainability, and grower profitability.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
- 4.4. Porter's Five Forces Analysis
- 4.5. PESTLE Analysis
- 4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
- 4.7. Go-to-Market Strategy
5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biological Seed Treatment Market, by Treatment Type
- 7.1. Seed Coating
- 7.1.1. Encrusting
- 7.1.2. Film Coating
- 7.2. Seed Dressing
- 7.3. Seed Pelleting
8. Biological Seed Treatment Market, by Seed Type
- 8.1. Treated Seed
- 8.2. Untreated Seed
9. Biological Seed Treatment Market, by Biological Agent
- 9.1. Bacteria
- 9.1.1. Rhizobium spp.
- 9.1.2. Bacillus spp.
- 9.1.3. Pseudomonas spp.
- 9.1.4. Azospirillum spp.
- 9.2. Fungi
- 9.2.1. Trichoderma spp.
- 9.2.2. Mycorrhizal Fungi
- 9.3. Virus
- 9.4. Algae
10. Biological Seed Treatment Market, by Formulation
- 10.1. Granule
- 10.2. Liquid
- 10.2.1. Oil Based
- 10.2.2. Water Based
- 10.3. Powder
11. Biological Seed Treatment Market, by Crop Type
- 11.1. Cereals
- 11.1.1. Corn
- 11.1.2. Rice
- 11.1.3. Wheat
- 11.2. Fruits & Vegetables
- 11.3. Oilseeds & Pulses
- 11.3.1. Rapeseed
- 11.3.2. Soybean
- 11.3.3. Sunflower
12. Biological Seed Treatment Market, by Sales Channel
- 12.1. Offline
- 12.2. Online
13. Biological Seed Treatment Market, by Region
- 13.1. Asia-Pacific
- 13.2. North America
- 13.3. Latin America
- 13.4. Europe
- 13.5. Middle East
- 13.6. Africa
14. Biological Seed Treatment Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
15. Biological Seed Treatment Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
16. Competitive Landscape
- 16.1. Market Concentration Analysis, 2025
- 16.1.1. Concentration Ratio (CR)
- 16.1.2. Herfindahl Hirschman Index (HHI)
- 16.2. Recent Developments & Impact Analysis, 2025
- 16.3. Product Portfolio Analysis, 2025
- 16.4. Benchmarking Analysis, 2025
17. Company Profiles
- 17.1. Agrinos AS
- 17.2. AMVAC Chemical Corporation
- 17.3. BASF SE
- 17.4. Bayer AG
- 17.5. Bioworks Inc
- 17.6. Certis USA LLC
- 17.7. Corteva Agriscience
- 17.8. East-West Seed
- 17.9. FMC Corporation
- 17.10. Germains Seed Technology
- 17.11. Groupe Limagrain SA
- 17.12. Incotec Group BV
- 17.13. Italpollina SpA
- 17.14. Koppert Biological Systems
- 17.15. Marrone Bio Innovations Inc
- 17.16. Novozymes A/S
- 17.17. Nufarm Limited
- 17.18. Plant Health Care plc
- 17.19. Rizobacter Argentina S.A.
- 17.20. SAKATA SEED CORPORATION
- 17.21. Sumitomo Chemical Co Ltd
- 17.22. Syngenta AG
- 17.23. UPL Limited
- 17.24. Valent BioSciences LLC
- 17.25. Verdesian Life Sciences LLC
